Skip to main content
. 2013 Jul 2;18(7):7699–7710. doi: 10.3390/molecules18077699

Table 4.

Central composite design (CCD) matrix for optimisation the antioxidant components.

Treatment runs α-tocopherol/astaxanthin (w/w) Ascorbic acid/astaxanthin (w/w)
1(C) 0.50 0.50
2(C) 0.50 0.50
3 0.15 0.15
4 0.50 0.00
5(C) 0.50 0.50
6 0.85 0.85
7(C) 0.50 0.50
8 0.15 0.85
9 0.50 1.00
10 0.00 0.50
11(C) 0.50 0.50
12 1.00 0.50
13 0.85 0.15

(C) Centre point.